Metropolitan Life Insurance Company (MetLife)’s SEQUENOM INC NEW SQNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-100,785
Closed -$142K 2711
2016
Q1
$142K Buy
+100,785
New +$150K ﹤0.01% 2364
2015
Q4
Sell
-91,239
Closed -$160K 2680
2015
Q3
$160K Buy
91,239
+49,603
+119% +$121K ﹤0.01% 2436
2015
Q2
$127K Sell
41,636
-52,969
-56% -$199K ﹤0.01% 2573
2015
Q1
$374K Sell
94,605
-180
-0.2% -$661 ﹤0.01% 1719
2014
Q4
$351K Hold
94,785
﹤0.01% 2014
2014
Q3
$282K Buy
94,785
+35,707
+60% +$131K ﹤0.01% 2129
2014
Q2
$229K Sell
59,078
-38,728
-40% -$113K ﹤0.01% 2416
2014
Q1
$240K Hold
97,806
﹤0.01% 2337
2013
Q4
$229K Hold
97,806
﹤0.01% 2377
2013
Q3
$261K Buy
97,806
+89
+0.1% +$299 ﹤0.01% 2220
2013
Q2
$411K Buy
+97,717
New +$391K ﹤0.01% 1820

Other funds holding SQNM

Metropolitan Life Insurance Company (MetLife)'s SQNM Position: Q2 2016 in Review

Metropolitan Life Insurance Company (MetLife) sold out of SEQUENOM INC NEW (SQNM) in Q2 2016, closing a stake of 100,785 shares — an estimated $142K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SQNM in Q2 2013 and held it in 11 quarters. The position peaked at $411K in Q2 2013. 91 funds tracked by Wall St. Rank hold SQNM as of Q2 2016.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining SEQUENOM INC NEW position as of Q2 2016 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 100,785 SEQUENOM INC NEW shares in Q2 2016, an estimated $142K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s SEQUENOM INC NEW position peaked at $411K in Q2 2013.
  • 91 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q2 2016.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2016, filed 16 Aug 2016.